SCHEMBL24512121

SCHEMBL24512121

Cc1ccc(-c2nnc(-c3ccccc3)[nH]2)cc1S(=O)(=O)N1C[C@H]2COC[C@H]2C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.46
CNR2 P34972 6/20 0.46
MAPT P10636 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
BRD4 O60885 2/20 0.40
BRD2 P25440 2/20 0.40
BRD3 Q15059 2/20 0.40
TP53 P04637 2/20 0.40
GAA P10253 1/20 0.40
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24512359 1.00 CNR1 (0.46) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL30899268 0.89 CNR1 (0.43) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL24512244 0.89 CNR1 (0.43) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL24512334 0.85 CNR1 (0.48) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL29717135 0.85 CNR1 (0.48) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL29717158 0.85 CNR1 (0.41) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL24512243 0.85 CNR1 (0.41) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL29717111 0.84 CNR1 (0.64) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL24512245 0.84 CNR1 (0.64) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL24512122 0.83 CNR2 (0.44) CNR1CNR2MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022125989-A1 COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS SCRIPPS RESEARCH INSTITUTE, THE (US) 2022-06-16 WO disclosed